跳至主要内容
临床试验/CTRI/2018/06/014579
CTRI/2018/06/014579招募中4 期

An Observational, prospective, comparative study of the effectiveness and safety of Liposomal Amphotericin-B versus Miltefosine in the treatment of Post Kala-Azar Dermal Leishmaniasis (PKDL).

Department of Pharmacology0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1)A clinical diagnosis of active PKDL with characteristic skin lesion.
  • 2)Confirmed diagnosis with biopsy of the skin (lesional segment) lesion.
  • 3)Male or female of age 18-65 yrs.

排除标准

  • 1)Pregnant or lactating women
  • 2)Refusal to use contraceptives during the treatment period and 2 months after completion of treatment with miltefosine
  • 3) HIV positive serology.
  • 4)Patients with co-morbid liver, kidney diseases
  • 5)Anaphylactic reaction with Amphotericin B

研究者

相似试验

Comparative study between Liposomal Amphoterisin B... | 临床试验